Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs PDS Biotechnology Corporation (PDSB)

Cue Biopharma, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Cue Biopharma, Inc. and PDS Biotechnology Corporation are of similar size ($136.1M and $129.2M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PDS Biotechnology Corporation leads on 9 and Cue Biopharma, Inc. on 3.

Valuation

Metric CUE PDSB Biotechnology median
P/E n/m n/m 10.60
P/S 3.15 n/m 9.40
P/B 51.41 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.74 n/m 9.02
Earnings yield (143.53%) (52.03%) (32.88%)
Free cash flow yield (42.21%) (24.15%) (23.13%)

Profitability

Metric CUE PDSB Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (543.97%) (51.96%)
Return on assets (459.60%) (136.65%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE PDSB Biotechnology median
Revenue growth (TTM) 354.37% — 6.76%
EPS growth (last fiscal year) 61.11% 28.16% 29.88%
Revenue growth, 5-year CAGR 54.16% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 1.25 0.57 4.97
Net debt to EBITDA 1.10 0.50 1.01

Dividend

Metric CUE PDSB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CUE PDSB Biotechnology median
Market cap 136.06m 129.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack